Equities

Strides Pharma Science Ltd

Strides Pharma Science Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)1,549.60
  • Today's Change-0.35 / -0.02%
  • Shares traded196.91k
  • 1 Year change+218.23%
  • Beta1.0973
Data delayed at least 15 minutes, as of Nov 08 2024 10:17 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Strides Pharma Science Limited is an India-based pharmaceutical company. The Company is focused on the development and manufacture of IP-led niche finished dosage formulations. The Company operates through two segments: Pharmaceutical and Bio-pharmaceutical. Its geographical segment includes Africa, Australia, Asia (excluding India), North America, Europe, India, and Others. The Company manufactures a range of niche and pharmaceutical products, including a range of dosage forms such as liquids, creams and ointments, soft gels, sachets, tablets, and modified release dosage formats. It has eight manufacturing units located in India (Bengaluru-two sites, Puducherry, and Chennai), Singapore, Italy (Milan), the United States (Florida) and Kenya (Nairobi). It is also engaged in manufacturing soft gelatin capsules. It develops and manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drug segments for its institutional business.

  • Revenue in INR (TTM)44.10bn
  • Net income in INR1.77bn
  • Incorporated1990
  • Employees3.07k
  • Location
    Strides Pharma Science LtdStrides HouseBilekahalli, Bannerghatta RoadBANGALORE 560076IndiaIND
  • Phone+91 8 067840000
  • Fax+91 8 067840700
  • Websitehttps://www.strides.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Procter & Gamble Health Ltd11.60bn2.18bn92.46bn1.41k42.48--37.837.97131.11131.11698.31------------------71.42--18.77----441.58-----6.37---12.42------
Blue Jet Healthcare Ltd7.22bn1.68bn94.15bn447.0056.0910.1949.1513.049.689.6841.6153.270.67321.973.4616,149,080.0015.66--19.57--55.65--23.26--2.51131.950.0012---1.30--2.33------
Sanofi Consumer Healthcare India Ltd8.01bn2.31bn113.01bn--48.9861.2248.2314.11100.17100.17347.6780.15----------------71.64--28.81--2.273,260.000.0986--------------
Akums Drugs and Pharmaceuticals Ltd-100.00bn-100.00bn125.32bn7.39k------------------------------------------------14.32---104.25------
Glenmark Life Sciences Ltd22.05bn4.24bn134.31bn2.01k31.805.2927.946.0934.4734.47179.44207.170.73041.462.7910,947,850.0014.0318.2816.6929.9954.9253.4019.2120.233.03380.550.006326.375.6420.830.84119.2169.11--
Marksans Pharma Ltd22.68bn3.34bn135.68bn2.00k40.61--32.735.987.377.3750.09--------11,339,960.00--14.62--18.5253.3950.5214.7114.03--32.19--6.1717.5616.8417.8032.6273.8664.38
Granules India Ltd44.78bn4.87bn141.66bn4.12k29.114.1320.293.1620.0820.08184.59141.410.83721.365.1410,863,290.009.1110.6814.0516.1859.3948.8310.8811.820.71526.880.24258.96-0.12314.61-21.5411.386.388.45
Strides Pharma Science Ltd44.10bn1.77bn142.50bn3.07k80.636.2738.343.2319.2225.15479.84247.160.71551.503.5714,389,290.002.79-1.685.43-2.9760.1951.393.91-3.360.63551.520.5103--9.8313.2143.57---18.52-3.58
Sanofi India Ltd21.92bn3.60bn148.59bn2.17k41.26--37.396.78156.36199.60951.86--------10,083,720.00--22.42--30.2153.9455.5216.4321.03--348.40--135.492.920.573-2.859.64-10.3414.73
Caplin Point Laboratories Ltd18.31bn4.94bn152.92bn859.0031.086.0127.328.3564.7364.73240.10334.540.68612.283.4021,312,920.0018.6219.8321.3622.8258.7253.3827.1425.395.07932.860.00099.0615.5021.1721.4820.9517.4717.84
Neuland Laboratories Ltd.15.28bn2.80bn176.96bn1.65k63.2712.7551.5011.58217.98217.981,191.201,081.520.8472.144.859,273,565.0015.509.2520.0312.7152.1447.8118.3011.991.4031.560.07287.1330.8418.5183.5178.7617.8863.45
Eris Lifesciences Ltd24.98bn3.48bn177.79bn3.08k51.086.4128.547.1225.5725.57183.35203.740.45852.905.968,110,753.006.7313.428.3916.8077.0379.9814.6924.960.85993.410.4626--19.2315.392.576.1527.72--
Astrazeneca Pharma India Ltd13.88bn958.59m182.67bn940.00190.56--164.7013.1638.3438.34555.18--------14,761,520.00--11.78--19.6248.5154.646.9110.27--121.25--25.6229.1712.2162.6624.29-10.46--
Wockhardt Ltd28.93bn-3.43bn189.68bn2.39k------6.56-23.75-23.75199.60--------12,084,380.00---4.56---8.2958.6655.26-12.17-12.70--0.0764----5.55-4.7317.17---4.71--
Concord Biotech Ltd10.38bn3.13bn193.54bn1.38k61.81--52.7518.6529.9329.9399.19--------7,537,496.00--------77.16--30.18----115.93----19.20--28.33------
Jubilant Pharmova Ltd69.20bn5.93bn196.25bn995.0033.143.3020.302.8437.3837.38436.41375.040.59341.758.1569,544,720.005.052.966.013.5568.5068.478.515.131.202.510.34224.736.70-5.95226.43-33.086.482.13
Data as of Nov 08 2024. Currency figures normalised to Strides Pharma Science Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

26.78%Per cent of shares held by top holders
HolderShares% Held
Route One Investment Co. LPas of 30 Sep 20246.65m7.23%
quant Money Managers Ltd.as of 31 Oct 20244.98m5.41%
Aditya Birla Sun Life Amc Ltd. (Investment Management)as of 10 Sep 20243.21m3.49%
The Vanguard Group, Inc.as of 02 Oct 20242.26m2.46%
SBI Life Insurance Co. Ltd. (Investment Portfolio)as of 30 Sep 20242.02m2.19%
Dimensional Fund Advisors LPas of 03 Oct 20241.47m1.60%
BlackRock Fund Advisorsas of 03 Oct 20241.24m1.34%
Max Life Insurance Co. Ltd.as of 30 Sep 20241.21m1.32%
Axis Asset Management Co. Ltd.as of 30 Sep 2024836.38k0.91%
Life Insurance Corporation of India (Investment Portfolio)as of 24 Oct 2024751.77k0.82%
More ▼
Data from 30 Jun 2024 - 31 Oct 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.